Baseline characteristics of patients and eyes
Baseline | Patients and eyes with completed follow-up years | ||||||
1 | 2 | 3 | 5 | 7 | 10 | ||
Patients, n | 3008 | 1964 | 1219 | 797 | 349 | 158 | 33 |
Age, years | |||||||
Median | 80 | 79 | 79 | 78 | 77 | 77 | 77 |
IQR | 74–85 | 74–84 | 73–84 | 73–83 | 72–81 | 72–81 | 73–81 |
Range | 50–101 | 52–101 | 52–97 | 54–97 | 54–93 | 56–92 | 60–92 |
Females, n | 2032 | 1342 | 822 | 543 | 240 | 111 | 23 |
% | 68 | 68 | 67 | 68 | 69 | 70 | 70 |
All eyes, n | 3844 | 2553 | 1615 | 1055 | 469 | 194 | 43 |
Baseline VA, mean | 55 | 59 | 61 | 62 | 63 | 62 | 61 |
SD | 20 | 17 | 16 | 16 | 14 | 16 | 16 |
Eyes with VA ≤35 ETDRS letters, n | 452 | 142 | 66 | 40 | 11 | 7 | 2 |
% | 12 | 6 | 4 | 4 | 2 | 4 | 5 |
Eyes with VA ≥70 ETDRS letters,† n | 744 | 773 | 403 | 281 | 133 | 56 | 12 |
% | 20 | 22 | 25 | 27 | 28 | 29 | 28 |
*Snellen equivalent ≤20/200 Snellen.
†Snellen equivalent ≥20/40 Snellen.
ETDRS, Early Treatment Diabetic Retinopathy Study; VA, visual acuity.